Cerus (CERS) Competitors $1.23 -0.02 (-1.60%) Closing price 09/12/2025 04:00 PM EasternExtended Trading$1.24 +0.01 (+0.41%) As of 09/12/2025 07:07 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Competitors Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFDA EventsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestTrendsBuy This Stock CERS vs. OSUR, UTMD, ANIK, WST, COO, ALGN, MMSI, ICUI, XRAY, and HAEShould you be buying Cerus stock or one of its competitors? The main competitors of Cerus include OraSure Technologies (OSUR), Utah Medical Products (UTMD), Anika Therapeutics (ANIK), West Pharmaceutical Services (WST), Cooper Companies (COO), Align Technology (ALGN), Merit Medical Systems (MMSI), ICU Medical (ICUI), DENTSPLY SIRONA (XRAY), and Haemonetics (HAE). These companies are all part of the "health care supplies" industry. Cerus vs. Its Competitors OraSure Technologies Utah Medical Products Anika Therapeutics West Pharmaceutical Services Cooper Companies Align Technology Merit Medical Systems ICU Medical DENTSPLY SIRONA Haemonetics Cerus (NASDAQ:CERS) and OraSure Technologies (NASDAQ:OSUR) are both small-cap medical companies, but which is the better business? We will contrast the two companies based on the strength of their institutional ownership, analyst recommendations, media sentiment, profitability, valuation, earnings, risk and dividends. Which has preferable earnings & valuation, CERS or OSUR? OraSure Technologies has higher revenue and earnings than Cerus. Cerus is trading at a lower price-to-earnings ratio than OraSure Technologies, indicating that it is currently the more affordable of the two stocks. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioCerus$180.27M1.31-$20.92M-$0.10-12.30OraSure Technologies$185.83M1.30-$19.50M-$0.67-4.94 Does the media prefer CERS or OSUR? In the previous week, OraSure Technologies had 2 more articles in the media than Cerus. MarketBeat recorded 7 mentions for OraSure Technologies and 5 mentions for Cerus. Cerus' average media sentiment score of 0.99 beat OraSure Technologies' score of 0.37 indicating that Cerus is being referred to more favorably in the media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment Cerus 2 Very Positive mention(s) 1 Positive mention(s) 0 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive OraSure Technologies 1 Very Positive mention(s) 1 Positive mention(s) 1 Neutral mention(s) 3 Negative mention(s) 0 Very Negative mention(s) Neutral Do insiders & institutionals hold more shares of CERS or OSUR? 78.4% of Cerus shares are held by institutional investors. Comparatively, 93.5% of OraSure Technologies shares are held by institutional investors. 3.4% of Cerus shares are held by insiders. Comparatively, 3.9% of OraSure Technologies shares are held by insiders. Strong institutional ownership is an indication that large money managers, endowments and hedge funds believe a stock will outperform the market over the long term. Do analysts rate CERS or OSUR? Cerus currently has a consensus price target of $3.50, suggesting a potential upside of 184.55%. OraSure Technologies has a consensus price target of $3.00, suggesting a potential downside of 9.37%. Given Cerus' stronger consensus rating and higher possible upside, equities analysts clearly believe Cerus is more favorable than OraSure Technologies.Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score Cerus 0 Sell rating(s) 0 Hold rating(s) 2 Buy rating(s) 0 Strong Buy rating(s) 3.00OraSure Technologies 0 Sell rating(s) 1 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 2.00 Which has more risk and volatility, CERS or OSUR? Cerus has a beta of 1.63, meaning that its share price is 63% more volatile than the S&P 500. Comparatively, OraSure Technologies has a beta of 0.44, meaning that its share price is 56% less volatile than the S&P 500. Is CERS or OSUR more profitable? Cerus has a net margin of -9.81% compared to OraSure Technologies' net margin of -36.84%. OraSure Technologies' return on equity of -10.81% beat Cerus' return on equity.Company Net Margins Return on Equity Return on Assets Cerus-9.81% -33.77% -9.32% OraSure Technologies -36.84%-10.81%-9.44% SummaryCerus beats OraSure Technologies on 9 of the 16 factors compared between the two stocks. Get Cerus News Delivered to You Automatically Sign up to receive the latest news and ratings for CERS and its competitors with MarketBeat's FREE daily newsletter. Subscribe Now View SMS TermsBy entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy. New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding CERS and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart CERS vs. The Competition Export to ExcelMetricCerusMED PRODUCTS IndustryMedical SectorNASDAQ ExchangeMarket Cap$235.79M$10.74B$5.79B$10.19BDividend YieldN/A1.88%5.73%4.60%P/E Ratio-12.3014.5756.5722.28Price / Sales1.3130.98529.93120.07Price / CashN/A25.0025.8129.91Price / Book3.973.5212.166.25Net Income-$20.92M$210.63M$3.29B$270.76M7 Day Performance-7.52%-0.18%0.74%3.87%1 Month Performance-3.15%2.04%5.00%5.49%1 Year Performance-40.58%-10.98%62.55%25.86% Cerus Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)CERSCerus2.8506 of 5 stars$1.23-1.6%$3.50+184.6%-40.6%$235.79M$180.27M-12.30290Short Interest ↓OSUROraSure Technologies1.9411 of 5 stars$3.25+0.6%$3.00-7.7%-25.6%$236.23M$185.83M-4.85840UTMDUtah Medical Products3.0316 of 5 stars$63.35-0.1%N/A-8.4%$203.24M$40.90M16.94180Positive NewsANIKAnika Therapeutics4.2794 of 5 stars$8.94flat$18.00+101.3%-64.8%$128.90M$114.55M-2.15300WSTWest Pharmaceutical Services4.9741 of 5 stars$253.30+1.0%$320.71+26.6%-15.7%$18.03B$2.89B37.9210,600News CoveragePositive NewsCOOCooper Companies4.4689 of 5 stars$68.79+1.0%$86.64+25.9%-39.7%$13.54B$3.90B33.8916,000Positive NewsALGNAlign Technology4.9553 of 5 stars$136.86-1.6%$215.00+57.1%-46.0%$10.08B$4.00B23.0820,945Positive NewsMMSIMerit Medical Systems4.7724 of 5 stars$92.33-0.7%$107.00+15.9%-11.1%$5.51B$1.36B46.877,400News CoveragePositive NewsICUIICU Medical4.6135 of 5 stars$130.58-0.5%$179.00+37.1%-27.2%$3.24B$2.37B-85.9115,000News CoveragePositive NewsAnalyst ForecastXRAYDENTSPLY SIRONA4.9651 of 5 stars$14.21-2.8%$18.64+31.1%-48.5%$2.92B$3.67B-3.0014,000Positive NewsHAEHaemonetics4.891 of 5 stars$54.02-0.7%$85.18+57.7%-31.4%$2.62B$1.35B16.523,023News CoverageAnalyst Revision Related Companies and Tools Related Companies OSUR Competitors UTMD Competitors ANIK Competitors WST Competitors COO Competitors ALGN Competitors MMSI Competitors ICUI Competitors XRAY Competitors HAE Competitors Top 10 Stock Comparisons Semiconductor Stocks Artificial Intelligence Stocks Growth Stocks Magnificent Seven Stocks Pharmaceutical Stocks Ecommerce Stocks Bitcoin Stocks Meme Stocks Cryptocurrency Stocks Cybersecurity Stocks This page (NASDAQ:CERS) was last updated on 9/14/2025 by MarketBeat.com Staff From Our PartnersCollege grad makes $64,000 a monthA Wall Street legend just helped train our own proprietary AI system in the stock market (a project that took ...Stansberry Research | SponsoredCrypto Gets Official Government Backing—Here's the WinnerTrump Just Signed the GENIUS Act—One Coin is About to Explode We're at the BEGINNING of smart money really ...Crypto 101 Media | SponsoredNvidia Times 1,000,000Nvidia’s latest AI chip is a $25,000 powerhouse — with 80 billion transistors and the ability to perform 60 tr...Paradigm Press | SponsoredElon’s Secret Social Security BombshellTo All Americans Born Before April 16th, 1963: Did Trump Just Give The Green Light To Radically RE-DO Social S...Banyan Hill Publishing | SponsoredTrump’s right about Epstein.A crisis that could devastate your wealth, upend the dollar, and accelerate the collapse of America’s economy....Porter & Company | SponsoredMarket Panic: Trump Just Dropped a Bomb on Your Stockstock Market Panic: Trump Just Dropped a Bomb on Your Stocks The market is in freefall—and Trump's new tarif...American Alternative | SponsoredDo NOT Day Trade (Do THIS instead)Forget day trading (especially in markets like these). Trade OVERNIGHT instead! I've uncovered a shockin...Monument Traders Alliance | SponsoredThe Obscure Korean War Act That Created a $5.39 Billion Passive Income StreamAn obscure Korean War law has just been enacted by the U.S. government... Allowing it to take a heavy hand ...Angel Publishing | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Cerus Corporation Please log in to your account or sign up in order to add this asset to your watchlist. Share Cerus With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
